Gender gap in stomach cancer care revealed in massive german study

NCT ID NCT06902337

Ongoing Knowledge-focused Sponsor: Medizinische Hochschule Brandenburg Theodor Fontane Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study examines whether men and women with gastric cancer receive different care in Germany. Researchers will analyze data from 75,000 patients treated between 2017 and 2021, looking at survival rates, complications, and treatment approaches. The goal is to identify gender-based disparities and help make cancer care more personalized and fair.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors tailor gastric cancer treatment based on gender, potentially improving survival and quality of care.
What could go wrong: This is an observational study using past data, so it cannot prove cause and effect. Results may not apply to other countries or healthcare systems.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTRIC ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gastric adenocarcinoma gastric neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GASTRIC ADENOCARCINOMA

Contacts and locations

Locations

Medical School Brandenburg

Brandenburg an der Havel, Brandenburg, 14770, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.